# A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

> **NCT00038025** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 60 (actual)

## Conditions studied

- Peripheral T-cell Lymphoma
- Cutaneous T-cell Lymphoma
- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Deoxycoformycin (DCF)

## Key facts

- **NCT ID:** NCT00038025
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-09-06
- **Primary completion:** 2006-11-29
- **Final completion:** 2006-11-29
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038025, "A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00038025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*